English  |  正體中文  |  简体中文  |  總筆數 :2856704  
造訪人次 :  53698963    線上人數 :  2025
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yu c j"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 801-810 / 2308 (共231頁)
<< < 76 77 78 79 80 81 82 83 84 85 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-02-23T08:26:43Z Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials Sung-Hsin Kuo;Yang C.-H.;Yu C.-J.;Hsu C.;Cheng A.-L.;Yang P.-C.; SUNG-HSIN KUO; Yang C.-H.; Yu C.-J.; Hsu C.; Cheng A.-L.; Yang P.-C.
臺大學術典藏 2021-02-23T08:26:39Z Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response Gow C.-H.;Chien C.-R.;Chang Y.-L.;Chiu Y.-H.;Sung-Hsin Kuo;Shih J.-Y.;Chang Y.-C.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; SUNG-HSIN KUO; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2021-02-23T08:26:37Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; SUNG-HSIN KUO; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2021-02-23T08:26:16Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Sung-Hsin Kuo;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; SUNG-HSIN KUO; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.
臺大學術典藏 2021-02-23T08:26:10Z Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer Yang W.-C.;Hsu F.-M.;Chen Y.-H.;Shih J.-Y.;Yu C.-J.;Lin Z.-Z.;Lu S.-H.;Yang J.C.-H.;Cheng A.-L.;Sung-Hsin Kuo; Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; SUNG-HSIN KUO
臺大學術典藏 2021-02-05T07:26:17Z Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis Kuei-Pin Chung;Chen J.-Y.;Lee C.-H.;Wu H.-D.;Wang J.-Y.;Lee L.-N.;Yu C.-J.;Yang P.-C.; KUEI-PIN CHUNG; Chen J.-Y.; Lee C.-H.; Wu H.-D.; Wang J.-Y.; Lee L.-N.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-02-05T07:26:17Z Alarmingly decreasing rates of amoxicillin-clavulanate susceptibility among clinical isolates of Haemophilus influenzae from 2001 to 2009 in a medical center in Taiwan Kuei-Pin Chung;Huang Y.-T.;Lee L.-N.;Yu C.-J.;Lai C.-C.;Hsueh P.-R.; KUEI-PIN CHUNG; Huang Y.-T.; Lee L.-N.; Yu C.-J.; Lai C.-C.; Hsueh P.-R.
臺大學術典藏 2021-02-05T07:26:17Z Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations Kuei-Pin Chung;Shih J.-Y.;Yu C.-J.; KUEI-PIN CHUNG; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-02-05T07:26:16Z Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment KUEI-PIN CHUNG; Huang Y.-T.; Chang Y.-L.; Yu C.-J.; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2021-02-05T07:26:14Z Central venous oxygen saturation under non-protocolized resuscitation is not related to survival in severe sepsis or septic shock KUEI-PIN CHUNG; Chang H.-T.; Huang Y.-T.; Liao C.-H.; Ho C.-C.; Jerng J.-S.; Yu C.-J.

顯示項目 801-810 / 2308 (共231頁)
<< < 76 77 78 79 80 81 82 83 84 85 > >>
每頁顯示[10|25|50]項目